CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 32 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $90,000 | -27.4% | 30,000 | 0.0% | 0.04% | -15.6% |
| Q2 2015 | $124,000 | -4.6% | 30,000 | 0.0% | 0.04% | -10.0% |
| Q1 2015 | $130,000 | +46.1% | 30,000 | 0.0% | 0.05% | +28.2% |
| Q4 2014 | $89,000 | -11.0% | 30,000 | 0.0% | 0.04% | -20.4% |
| Q3 2014 | $100,000 | +31.6% | 30,000 | 0.0% | 0.05% | +32.4% |
| Q2 2014 | $76,000 | +11.8% | 30,000 | 0.0% | 0.04% | -9.8% |
| Q1 2014 | $68,000 | +15.3% | 30,000 | 0.0% | 0.04% | +17.1% |
| Q4 2013 | $59,000 | – | 30,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |